Table 4. Comparison of results of patients with normal vs. abnormal EF.
| AEF (n = 114) | NEF (n = 252) | p | |
|---|---|---|---|
| Age (years) | 73.9 ± 11.6 | 72.3 ± 13.5 | 0.278 |
| Female gender | 66 (58%) | 109 (43%) | 0.013 |
| Mortality | 40 (35%) | 63 (25%) | 0.050 |
| SBP (mmHg) | 122 ± 22 | 123 ± 21 | 0.751 |
| DBP | 68 ± 15 | 69 ± 14 | 0.697 |
| Heart rate (bpm) | 97 ± 25 | 91 ± 19 | 0.030 |
| Body mass index (kg/m2) | 22.0 ± 4.5 | 22.7 ± 4.3 | 0.158 |
| Site of infection | 0.353 | ||
| Pneumonia | 55 (48%) | 95 (38%) | *0.066 |
| Hypertension | 54 (47%) | 105 (42%) | 0.362 |
| Diabetes | 34 (30%) | 71 (28%) | 0.803 |
| Cerebrovascular ds | 42 (37%) | 96 (38%) | 0.907 |
| Cardiovascular ds | 12 (11%) | 30 (12%) | 0.860 |
| ICU days | 8.5 ± 9.6 | 12.9 ± 19.6 | 0.004 |
| Hospital days | 19.7 ± 17.3 | 25.5 ± 22.2 | 0.007 |
| SAPS3 | 34.9 ± 6.6 | 35.3 ± 7.6 | 0.672 |
| Initial CVP | 5.3 ± 3.1 | 6.0 ± 3.6 | 0.149 |
| TnI1 | 0.49 ± 1.72 | 0.21 ± 0.81 | 0.134 |
| TnI2 | 2.46 ± 7.78 | 1.33 ± 4.08 | 0.217 |
| TnI3 | 0.82 ± 1.54 | 0.92 ± 5.81 | 0.915 |
| CK-MB | 10.36 ± 23.93 | 6.9 ± 15.6 | 0.161 |
| BNP | 547.4 ± 885.6 | 374 ± 981 | 0.115 |
| cr | 1.4 ± 1.3 | 1.5 ± 1.2 | 0.699 |
| CRPpeak | 194.6 ± 96.0 | 221.5 ± 144.7 | 0.072 |
| LVEDD | 44.9 ± 6.4 | 45.8 ± 6.3 | 0.202 |
| LVESD | 29.2 ± 8.1 | 30.5 ± 4.5 | 0.117 |
| LAVI | 19.2 ± 11.7 | 23.0 ± 13.7 | 0.015 |
| LMVI | 92.9 ± 24.9 | 96.7 ± 27.5 | 0.214 |
| E velocity | 70.5 ± 23.4 | 70.4 ± 22.6 | 0.974 |
| A velocity | 85.0 ± 25.6 | 83.3 ± 23.3 | 0.576 |
| DT | 182.0 ± 46.5 | 187.6 ± 46.2 | 0.329 |
| E/E’ | 12.1 ± 5.5 | 12.3 ± 5.2 | 0.759 |
| S’ | 7.8 ± 2.5 | 7.9 ± 2.4 | 0.641 |
| GS | -16.0 ± 4.9 | -17.3 ± 2.8 | 0.207 |
| MPI | 0.43 ± 0.20 | 0.43 ± 0.20 | 0.910 |
| RVSP | 35.0 ± 10.4 | 33.4 ± 11.2 | 0.199 |